Aqr Capital Management LLC Atara Biotherapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $135,010 - $374,347	-306,842 Reduced 10.46%	2,625,468 $1.81 Million
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $480,207 - $3.63 Million	2,087,858 Added 247.24%	2,932,310 $1.5 Million
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.31 $954,813 - $1.56 Million	677,173 Added 404.82%	844,452 $1.25 Million
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $174,472 - $353,597	116,315 Added 228.23%	167,279 $269,000
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $237,246 - $462,631	-84,731 Reduced 62.44%	50,964 $147,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $1.07 Million - $1.94 Million	-374,474 Reduced 73.4%	135,695 $445,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $1.45 Million - $4.45 Million	510,169 New	510,169 $1.93 Million
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $156,655 - $328,675	-33,402 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $281,912 - $564,159	33,402 New	33,402 $310,000
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $318,442 - $475,406	-26,559 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $252,927 - $325,332	-19,622 Reduced 42.49%	26,559 $413,000
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $348,488 - $515,762	24,892 Added 116.92%	46,181 $663,000
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $269,731 - $558,410	21,289 New	21,289 $418,000
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $122,708 - $189,189	-11,268 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $135,554 - $224,683	11,268 New	11,268 $159,000
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $195,986 - $422,219	-10,288 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$28.4 - $41.74 $304,135 - $446,993	-10,709 Reduced 51.0%	10,288 $409,000
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $18,910 - $26,297	-612 Reduced 2.83%	20,997 $729,000
Q3 2018 Nov 15, 2018	BUY	$35.05 - $43.5 $85,486 - $106,096	2,439 Added 12.72%	21,609 $894,000
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $415,789 - $608,602	11,829 Added 161.14%	19,170 $704,000
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $132,138 - $354,937	7,341 New	7,341 $286,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account